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Abstract
Objective—To explore whether recently enacted infertility mandates including coverage for 
assisted reproductive technology (ART) treatment in New Jersey (2001) and Connecticut (2005) 
increased ART use, improved embryo transfer practices, and decreased multiple birth rates.
Design—Retrospective cohort study using data from the National ART Surveillance System. We 
explored trends in ART use, embryo transfer practices and birth outcomes, and compared changes 
in practices and outcomes during a 2-year period before and after passing the mandate between 
mandate and non-mandate states.
Setting—Not applicable.
Patient(s)—Cycles of ART performed in the United States between 1996 and 2013.
Intervention(s)—Infertility insurance mandates including coverage for ART treatment passed in 
New Jersey (2001) and Connecticut (2005).
Main Outcome Measures(s)—Number of ART cycles performed, number of embryos 
transferred, multiple live birth rates.
Result(s)—Both New Jersey and Connecticut experienced an increase in ART use greater than 
the non-mandate states. The mean number of embryos transferred decreased significantly in New 
Jersey and Connecticut; however, the magnitudes were not significantly different from non-
mandate states. There was no significant change in ART birth outcomes in either mandate state 
except for an increase in live births in Connecticut; the magnitude was not different from non-
mandate states.
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Conclusion(s)—The infertility insurance mandates passed in New Jersey and Connecticut were 
associated with increased ART treatment use but not a decrease in the number of embryos 
transferred or the rate of multiples; however, applicability of the mandates was limited.
Keywords
Infertility insurance mandate; embryo transfer; multiple births; assisted reproductive technology 
(ART); in vitro fertilization (IVF)
The increased use of assisted reproductive technology (ART) and non-ART fertility 
treatments over time has led to an increase in the multiple birth rate (1). Assisted 
reproductive technology cycles average $12,400 for fresh, autologous cycles in the United 
States (2). Because the majority of patients in the United States pay for ART directly out of 
pocket, financial pressure can lead patients to transfer more than one embryo to maximize 
their chance for success, thus increasing multiple births. However, multiple births are 
associated with increased health risks to mother and infants (3, 4).
Infertility insurance mandates require that private insurers cover some costs associated with 
infertility diagnosis and treatment. Infertility mandates that include coverage for ART can 
reduce pressure to transfer multiple embryos during an ART cycle. Currently 15 states have 
infertility-related insurance mandates; only 8 require coverage for ART, among which there 
are various treatment restrictions, and patient and employer exemptions (5–9). Previous 
studies of infertility-related insurance mandates compared embryo transfer (ET) practices 
and ART treatment outcomes in mandate states with those in non-mandate states; however, 
observed effects could reflect differences in patient populations rather than insurance 
mandates (6–8,10–13).
The Centers for Disease Control and Prevention collects data on all United States ART 
cycles and outcomes per the Fertility Clinic Success Rate and Certification Act of 1992 (14). 
Because data collection began in 1995, only Connecticut and New Jersey have implemented 
infertility insurance mandates that include ART coverage. The objectives of this study were 
to explore changes in ART use, ART practice, and ART birth outcomes after the 




We analyzed data from the Centers for Disease Control and Prevention’s National ART 
Surveillance System and annual, state-specific population data prepared by the Census 
Bureau in collaboration with the National Center for Health Statistics, namely 1996–1999 
bridged-race intercensal, 2000–2009 revised bridged-race intercensal, and 2010–2013 
bridged-race vintage 2013 postcensal July 1 estimates (15, 16).
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Infertility insurance mandates including coverage for ART were enacted in New Jersey on 
August 31, 2001 and in Connecticut on October 1, 2005 (17, 18). The New Jersey mandate 
applies to patients younger than 46 years and includes women younger than 35 years who 
are unable to conceive over a 2-year period, women aged 35 years and older who are unable 
to conceive over a 1-year period, men unable to impregnate a woman, women unable to 
carry a pregnancy to live birth, and anyone with medical sterility. The Connecticut mandate 
applies to patients younger than 40 years who are unable to conceive or sustain a successful 
pregnancy within a 1-year period and who have been covered by a policy for at least 12 
months. The New Jersey mandate covers a total of four egg retrievals along with all 
associated ART, fresh and frozen embryo transfers, assisted hatching, intracytoplasmic 
sperm injection (ICSI), and medications, whereas the Connecticut mandate covers at most 
two cycles of ART, with each fertilization or transfer counting as one cycle. Connecticut also 
limits each cycle to “not more than 2 embryo implantations per cycle” (18), whereas New 
Jersey has no such limitations. In addition to ART coverage, the New Jersey mandate covers 
artificial insemination, ovulation induction, and surgery, whereas the Connecticut mandate 
covers four cycles of ovulation induction and three cycles of IUI. Both states require patients 
to use less-costly procedures first. Both states allow exclusions for religious employers and 
employers who self-insure, and New Jersey also exempts employers with fewer than 50 
employees (5).
Statistical Methods
We explored trends in ART use, ART practice, and ART birth outcomes among all ART 
cycles for New Jersey, Connecticut, and all four states in the Northeast census region that do 
not have any infertility insurance mandate (the non-mandate states: Maine, New Hampshire, 
Pennsylvania, and Vermont) from 1996 through 2013. These four states were chosen for 
their close geographic proximity to New Jersey and Connecticut, resulting in more similarity 
between the states being compared. We excluded banking cycles resulting in the 
cryopreservation of all oocytes or embryos and research cycles evaluating new procedures. 
An ART use ratio was calculated as the number of cycles performed per 1,000 women in the 
population aged 15–44 years. We compared the percentage change in each measure from the 
year the mandate passed to the following year between the mandate and non-mandate states.
We generated 2-year pre- and post-mandate periods for each mandate state to explore ET 
procedures started directly before and after the mandates were passed for fresh non-donor 
cycles resulting in transfer. We used a 2-year period to provide enough time for a transition 
period after the mandates went into effect, but also to limit other changes in ART practice 
and birth outcomes in this rapidly changing field. For New Jersey, the periods were 
September 1, 1999 through August 31, 2001 and September 1, 2001 through August 31, 
2003; for Connecticut, they were October 1, 2003 through September 30, 2005 and October 
1, 2005 through September 30, 2007. We included the birth outcomes for all transfers started 
during these time periods, even if the birth outcome occurred later. Data for the same time 
periods in the non-mandate states were used for comparison. A 4-year pre-and post-mandate 
period was explored to assess sensitivity to time period length; stratification by the female 
patient’s age at the time the cycle was started was explored to assess sensitivity to patient 
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population; and a comparison group of all 35 states and the District of Columbia without 
infertility insurance mandates was explored to assess the impact of using a limited 
comparison group vs. all non-mandate states.
We looked at the associations between mandate period (pre-/post-mandate) and ART patient 
characteristics for mandate and non-mandate states using a Rao-Scott χ2 test to account for 
clinic-level clustering. We explored associations between mandate period and ART use using 
Poisson regression for the number of cycles started per year, accounting for the female 15–
44-year population. Because we had annual population estimates, we approximated the 
population using the year that covered the majority of the time period. For example, in New 
Jersey, for the number of cycles that occurred between September 1, 1999 and August 31, 
2000, we approximated the population size using the 2000 population estimate. We explored 
associations between mandate period and ART practice and outcomes using Poisson 
regression for the number of days between retrieval and transfer (to determine whether any 
shift in cleavage vs. blastocyst transfers), number of embryos transferred, and number of 
embryos cryopreserved, and log-binomial regression for transfers of more than two 
embryos, assisted hatching, ICSI, live births, multiple live births resulting in the birth of 
more than one infant, preterm live births, and low birth weight live births. Generalized 
estimating equations with an independent correlation matrix were used to account for clinic-
level clustering for all regression models except those assessing ART use. All models 
included an indicator for mandate period, an indicator for whether the transfer occurred in 
the mandate state, and an interaction term to assess whether the relationship between each 
outcome and the mandate period differed by state mandate status; the latter measure was 
included to account for possible changes occurring in ART practice and outcomes overall 
apart from the mandate. All analyses were conducted using SAS version 9.3 (SAS Institute). 
Statistical significance was set at P<.05. This study was approved by the institutional review 
board of the Centers for Disease Control and Prevention.
RESULTS
Trends in ART use, Practice, and Birth Outcomes
The ART use ratios were higher for the entire study period in New Jersey and Connecticut 
than in the non-mandate states (Fig. 1A). From 2001 to 2002, the ART use ratio in New 
Jersey increased by 27.9% (3.0–3.9) and in the non-mandate states by 9.8% (1.4–1.5). From 
2005 to 2006, the ART use ratio in Connecticut increased by 23.4% (3.8–4.7), whereas the 
ratio in the non-mandate states decreased by 7.0% (1.8–1.7). New Jersey, Connecticut, and 
the non-mandate states all experienced a downward trend in the percentage of transfers of 
more than two embryos (Fig. 1B). The percentage decrease from 2001 to 2002 was larger in 
New Jersey at 16.1% (62.6%–52.5%) than in the non-mandate states at 8.1% (69.2%–
63.6%). The percentage decrease from 2005 to 2006 was similar in Connecticut at 13.1% 
(45.9%–39.9%) and the non-mandate states at 14.0% (47.4%–40.8%). The percentage of 
transfers resulting in a multiple live birth decreased by 5.9% (13.8%–13.0%) from 2001 to 
2002 in New Jersey and increased by 8.2% (8.9%–9.6%) from 2001 to 2002 in the non-
mandate states (Fig. 1C). From 2005 to 2006, the percentage of multiple births decreased by 
7.0% (10.7%–10.0%) in Connecticut and by 5.1% (8.9%–8.5%) in the non-mandate states.
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After the New Jersey mandate passed, there was a significant increase in New Jersey in the 
percentage of transfers among women older than 40 years (10.5%–12.5%) and a significant 
decrease among patients with endometriosis (16.7%–14.1%) (Table 1). Both in New Jersey 
and the non-mandate states, there was a significant decline in the percentage of transfers 
after a retrieval of five or more oocytes (New Jersey: 92.7%–90.0%; non-mandate: 90.2%–
88.7%), and among patients with tubal factor (New Jersey: 25.7%–22.9%; non-mandate 
states: 27.5%–23.9%). In the non-mandate states, there was a significant increase in the 
percentage of transfers among patients with diminished ovarian reserve (7.9%–13.2%).
After the Connecticut mandate passed, there was a significant increase in Connecticut in the 
percentage of transfers to non-Hispanic blacks (3.8%–6.5%) and Hispanics (suppressed for 
confidentiality); in the non-mandate states, there was a significant increase in the percentage 
of transfers among Asians/Pacific Islanders (4.3%–5.6%). Connecticut experienced a 
significant increase in the percentage of transfers among patients with diminished ovarian 
reserve (8.2%–11.1%) and a decrease in the percentage of transfers among patients with two 
or more ART cycles (29.6%–24.2%). The non-mandate states experienced an increase in the 
percentage of transfers among patients with ovulatory dysfunction (13.8%–15.7%) or with 
unexplained infertility (13.6%–10.9%) and a decrease in the percentage of transfers among 
patients with no prior pregnancies (51.5%–43.9%), no prior births (72.5%–69.5%), or 
endometriosis (15.5%–13.5%).
Note that decreases in the percentage of transfers after the mandates were often associated 
with increases in the number of transfers owing to the increased number of cycles conducted 
after the mandates.
ART use
The number of cycles per 1,000 females aged 15–44 years of age significantly increased 
after the mandate in New Jersey (risk ratio [RR] 1.45, 95% confidence interval [CI] 1.41–
1.48) and in the non-mandate states (RR 1.26, 95% CI 1.22–1.30); however, the increase in 
ART use in New Jersey was larger than the increase in the non-mandate states (interaction 
P<.001) (Table 2). After the mandate passed in Connecticut, ART use significantly increased 
in Connecticut (RR 1.22, 95% CI 1.18–1.27) (Table 3). No significant change was observed 
in the non-mandate states. The increase in ART use observed in Connecticut was 
significantly larger than in the non-mandate states (interaction P<.001).
ART Practice
The changes in ART practice across mandate periods in New Jersey were not significantly 
different from those in the non-mandate states (Table 2). In New Jersey, after the mandate 
passed, the mean number of days between retrieval and transfer significantly increased (RR 
1.04, 95% CI 1.005–1.07) (Table 2). This increase was not significantly greater than in the 
non-mandate states, where there was no significant change. The percentage of transfers 
using ICSI increased significantly in the non-mandate group only (RR 1.11, 95% CI 1.04–
1.19) but not significantly more than the non-significant increase in New Jersey. The mean 
number of embryos transferred and the percentage of transfers of more than two embryos 
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decreased significantly in New Jersey (RR 0.89, 95% CI 0.86–0.93; and RR 0.80, 95% CI 
0.72–0.90, respectively); however, these decreases were not significantly different than the 
decreases in the non-mandate states. Neither group saw a significant change in embryo 
cryopreservation or assisted hatching.
The changes in ART practice across mandate periods also were not significantly different 
between Connecticut and the non-mandate states (Table 3). After the mandate passed, the 
percentage of transfers using ICSI increased in Connecticut (RR 1.07, 95% CI 1.02–1.12), 
but the increase was not significantly greater than the non-significant increase in the non-
mandate states. The mean number of embryos transferred and the percentage of transfers of 
more than two embryos decreased significantly in Connecticut (RR 0.95, 95% CI 0.91–0.99; 
and RR 0.83, 95% CI=0.73–0.93, respectively); these decreases in embryos transferred were 
not significantly different than the decreases in the non-mandate states. Neither group saw a 
significant change in the mean number of days between retrieval and transfer, embryo 
cryopreservation, or assisted hatching.
ART Birth Outcomes
There were no significant changes in New Jersey in the percentages of transfers resulting in 
live birth, multiple, preterm, or low birth weight live birth after the mandate; however, the 
non-mandate states experienced significant increases in live births (RR 1.14, 95% CI 1.06–
1.23) and multiple births (RR 1.21, 95% CI 1.07–1.37) (Table 2), which were significantly 
larger than the non-significant increase and decrease in New Jersey (P=.049 and P=.005, 
respectively).
Both Connecticut and the non-mandate states experienced an increase in the percentage of 
transfers resulting in a live birth (Connecticut: RR 1.07, 95% CI 1.02–1.12; non-mandate 
states: RR 1.10; 95% CI 1.05–1.16); however, there was no significant difference in the 
increases between Connecticut and the non-mandate states (Table 3). The non-mandate 
states also experienced a significant increase in low birth weight live births (RR 1.14, 95% 
CI 1.02–1.27), but it was not significantly different than the non-significant decrease 
observed in Connecticut. There were no significant changes in multiple or preterm live births 
for either Connecticut or the non-mandate states.
Subanalysis
When the pre- and post-mandate periods were expanded to 4 years, the decreases in the 
average number of embryos transferred and the percentage of transfers of more than two 
embryos in the non-mandate states were significantly larger than in New Jersey. A similar 
result occurred in Connecticut, where the decrease in the average number of embryos 
transferred in the non-mandates states was now significantly larger than the decrease in 
Connecticut. New Jersey also now observed a significant increase in the percentage of 
transfers using ICSI. However, the increase in the non-mandate states was significantly 
larger than in the mandate states. There was a significant difference in all of the ART birth 
outcomes between New Jersey and the non-mandate states, with the non-mandate states 
experiencing a significant increase in live births, multiple live births, preterm live births, and 
Crawford et al. Page 6













low birth weight live births whereas New Jersey experienced no significant changes in any 
of the birth outcomes.
When stratified by age group, the increase in ART use in the mandate states was no longer 
significantly larger than the increase in use in the non-mandate states for those aged 40 years 
and older in New Jersey and those aged 35–39 years in Connecticut. With regard to ART 
practice, in Connecticut, for those aged 35–39 years, the significant increase in ICSI was 
now significantly higher than the increase in ICSI in the non-mandate states. In addition, the 
decrease in the average number of embryos transferred in the non-mandate states now was 
significantly larger than in Connecticut for those aged 35–39 years, whereas for those aged 
40 years or older there was no significant decrease in the average number of embryos 
transferred. Similarly, among those aged 40 years and older, New Jersey experienced a 
significant decrease in the percentage of transfers of more than two embryos that was 
significantly larger than the decrease in the non-mandate states. With regard to birth 
outcomes, although the analysis combining all age groups showed an increase in live births 
and multiple live births among non-mandates states that was significantly larger than in New 
Jersey, the differences were not statistically significant when explored by age group.
When all states and the District of Columbia without an insurance mandate were included in 
the control group, rather than just those states in the Northeast, the increase in the percentage 
of transfers resulting in live births among the non-mandate states was no longer significantly 
larger than the change in live births in New Jersey. In addition, there was a significant 
increase in the mean number of days between retrieval and transfer in the non-mandate 
states that was significantly larger than the non-significant increase in Connecticut.
DISCUSSION
After the infertility mandates, both New Jersey and Connecticut experienced an increase in 
ART use greater than in the non-mandate states. Connecticut and New Jersey also 
experienced some decrease in the percentage of transfers of more than two embryos and the 
average number of embryos transferred; however, these improvements in ET practices were 
not different from the improvements in the non-mandate states, suggesting overall 
improvements across the ART community vs. improvements due to the mandate. Our results 
also do not indicate a mandate effect on ART outcomes, with the possible exception of fewer 
live births and multiple births in New Jersey compared with the non-mandate states. When 
analyzed by age group, the live birth and multiple birth RRs did not indicate a significant 
difference between New Jersey and the non-mandate states. Thus, the fewer live births and 
multiple births may be due to the larger proportion of cycles among women aged 41 years or 
older in New Jersey after the mandate.
Other studies in the United States have compared ET practices and treatment outcomes in 
states with insurance mandates with those in states without insurance mandates, but results 
are mixed. Several studies found states with mandates had higher ART use (10, 11) and 
transferred fewer embryos (8,11–13), some reported a decrease in multiple birth rates but 
also pregnancy rates (8, 10, 11), and others did not see any conclusive effect on pregnancy or 
birth rates (6, 12, 13). A study by Hamilton et al. (7) found that only states with universal 
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mandates with no employer exceptions saw increased treatment access and improved ET 
practices, whereas states with other types of mandates (including New Jersey and 
Connecticut) experienced little effect. Other countries, including Belgium and Canada, 
found ART coverage effective at increasing ART use while reducing multiple births when 
coverage is comprehensive and accompanied by ET restrictions (19–21).
Although the infertility mandates may lead to wider access to ART treatment, increased use 
may lead to increased multiples: Connecticut and New Jersey now have some of the highest 
proportions of multiple infants among all infants born to state residents, at 4.2% and 4.5%, 
respectively (22). Although an increase in use was observed in Connecticut and New Jersey 
after the mandates were passed, there were no notable changes in ET practices, and fewer 
live births and multiple births, but only in New Jersey. It is possible that insurance coverage 
for ART may not positively affect ET practices and birth outcomes; however, the lack of an 
observed effect may be due to other factors. The mandates in New Jersey and Connecticut 
both exclude religious employers and employers that self-insure; New Jersey’s mandate also 
excludes employers with fewer than 50 employees, thereby limiting those employees to 
whom the mandate applies. In 2002, after the New Jersey mandate passed, 72.2% of New 
Jersey’s private sector employees were employed by a company employing at least 50 
employees. Of those employed by a company of 50 or more, 98.1% were offered insurance; 
of those offered, 66.0% enrolled; of those that enrolled, 33.0% enrolled in a plan that was 
not self-insured (23). In 2006, after the Connecticut mandate passed, 93.6% of private sector 
employees were offered insurance; of those offered, 63.3% enrolled; of those that enrolled, 
51.9% enrolled in a plan that was not self-insured (24). Another factor possibly contributing 
to the lack of effect is the increase in ART use that may mask improvement in ET practices. 
Although decreases in the percentage of cycles conducted with certain patient or cycle 
characteristics or with certain outcomes were observed after the mandate, these decreases in 
percentages often coincided with an increase in the raw number of cycles due to the increase 
in ART use. Finally, limitations in infertility coverage in the mandate states (lack of 
coverage for some ART patients, out-of-pocket costs remaining after insurance coverage, 
exhaustion of insurance benefits before treatment is completed) also may have contributed.
This study has several strengths. It includes data before and after insurance mandates were 
passed, accounting for differences between states. It also accounts for major changes in the 
field of ART by making comparisons with non-mandate states. However, it did not include 
information on which ART cycles were covered by the mandate in light of the employer 
exclusions or which ART cycles were paid for with insurance, and it did not include all 
states with ART insurance mandates. It is also dependent on the specifics of the mandates 
themselves, including coverage of ART treatment and other infertility treatments, which 
vary by state. In addition, the mandate coverage was determined by state of residence, 
whereas state of the employer actually determines whether the mandate is applicable. In the 
Northeast, the small size and close proximity of states may result in some patients being 
misclassified with regard to mandate group; the direction of the bias from this possible 
misclassification is unknown, because it would depend on how many people residing in 
states with and without a mandate were working in a state with a different mandate status. 
Finally, differences in outcomes per transfer are more difficult to detect statistically than 
differences in ET practices because a large proportion of transfers do not result in pregnancy.
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Although our study does suggest that the infertility insurance mandates in New Jersey and 
Connecticut were associated with increased ART use, the results do not suggest that the 
mandates were effective at improving overall ET practices or reducing adverse ART birth 
outcomes in these states. However, the mandates studied here only apply to a small 
proportion of employees in the private sector. Universal mandates with a restriction on the 
number of embryos transferred may still be effective in reducing the number of embryos 
transferred and adverse ART birth outcomes.
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Trends in ART, 1996–2013. (A) Trends in the use of ART; (B) trends in the transfer of more 
than two embryos; (C) trends in multiple live births from 1996 through 2013. Panel (A) 
excludes ART cycles in which all oocytes or embryos were cryopreserved (banking cycles) 
or new procedures were evaluated (research cycles), whereas (B) and (C) exclude cycles not 
resulting in the transfer of at least one embryo. The ART use ratio is calculated as the 
number of cycles performed per 1,000 women in the population aged 15–44 years, or in the 
age group specified. The vertical line indicates the passing of an infertility mandate with 
ART coverage in New Jersey or Connecticut. “Non-mandate” refers to states without 
mandates for infertility coverage during the study period located in the Northeast census 
region, including Maine, New Hampshire, Pennsylvania, and Vermont.
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